Rituximab for passenger lymphocyte syndrome associated with allogeneic SCT

Bone Marrow Transplantation

Volumn 42, Issue 1, 2008, Pages 67-69

  Lee, H J ^a   Gulbis, A ^b   De Padua Silva, L ^b   Hosing, C ^b   Khouri, I ^b   de Lima, M ^b   Champlin, R E ^b   Ciurea, S O ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; COMPLEMENT; ERYTHROCYTE ANTIBODY; FLUDARABINE; GEMTUZUMAB OZOGAMICIN; HAPTOGLOBIN; HEMOGLOBIN; HLA ANTIGEN; IMMUNOGLOBULIN G; LACTATE DEHYDROGENASE; MELPHALAN; METHYLPREDNISOLONE; RITUXIMAB; THYMOCYTE ANTIBODY;

AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BLOOD ANALYSIS; CASE REPORT; COOMBS TEST; DISEASE COURSE; ERYTHROCYTE TRANSFUSION; FEMALE; GRAFT VERSUS HOST REACTION; HEMOGLOBINURIA; HEMOLYTIC ANEMIA; HLA MATCHING; HOSPITAL ADMISSION; HUMAN; HYPERBILIRUBINEMIA; MYELOMONOCYTIC LEUKEMIA; PASSENGER LYMPHOCYTE SYNDROME; PRIORITY JOURNAL; TREATMENT OUTCOME;

ABO BLOOD-GROUP SYSTEM; AGED; ANEMIA, HEMOLYTIC; ANTIBODIES, MONOCLONAL; B-LYMPHOCYTES; BLOOD GROUP INCOMPATIBILITY; BLOOD TRANSFUSION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOLOGIC FACTORS; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; SYNDROME; TRANSPLANTATION, HOMOLOGOUS;

EID: 48949116731     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.79     Document Type: Article

References (10)

1. Yazer MH, Triulzi DJ. Immune hemolysis following ABO-mismatched stem cell or solid organ transplantation. Curr Opin Hematol 2007; 14 664-670.
2. Horn B, Viele, M, Mentzer W, Mogck N, DeSantes K, Cowan M. Autoimmune hemolytic anemia in patients with SCID after T cell-depleted BM and PBSC transplantation. Bone Marrow Transplant 1999; 24: 1009-1013.
3. Hows J, Beddow K, Gordon-Smith E, Branch DR, Spruce W, Sniecinski I et al. Donor-derived red blood cell antibodies and immune hemolysis after allogen, bone marrow transplantation. Blood 1986; 67: 177-181.
4. Toren A, Dacosta Y, Manny N, Varadi G, Or R, Nagler A. Passenger B-lymphocyte-induced severe hemolytic disease after allogeneic peripheral blood stem cell transplantation. Blood 1996; 87: 843-844.
5. Panaro F, DeChristopher PJ, Rondelli D, Testa G, Sankary H, Popescu M et al. Severe hemolytic anemia due to passenger lymphocytes after living-related bowel transplant. Clin Transplant 2004; 18: 332-335.
6. Sokol RJ, Stamps R, Booker DJ, Scott FM, Laidlaw ST, Vandenberghe EA et al. Post transplant immune-mediated hemolysis. Transfusion 2002; 42: 198-204.
7. de Lima M, Champlin RE, Thall PF, Wang X, Martin III TG, Cook JD et al. Phase 1/11 study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome. Leukemia 2007.
8. Gajewski JL, Petz LD, Calhoun L, O'Rourke S, Landaw EM, Lyddane NR et al. Hemolysis of transfused group O red blood cells in minor ABO- incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate. Blood 1992; 79: 3076-3085.
9. Corti P, Bonanomi S, Vallinoto C, Balduzzi A, Uderzo C, Cazzaniga G et al. Rituximab for immune hemolytic anemia following T- and B-Cell-depleted hematopoietic: Stem cell transplantation. Acta Haematol 2003; 109: 43-45.
10. Ship A, May W, Lucas K. Anti-CD20 monoclonal antibody therapy for autoimmune hemolytic anemia following T cell-depleted, haplo-identical stem cell transplantation. Bone Marrow Transplant 2002; 29: 365-366.